Publications (25) Publications auxquelles un chercheur a participé

2001

  1. A specific and ultrasensitive chemiluminescent sandwich ELISA test for the detection and quantitation of pneumolysin

    Journal of Immunoassay and Immunochemistry, Vol. 22, Núm. 2, pp. 99-112

  2. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain

    AIDS, Vol. 15, Núm. 14, pp. 1894-1896

  3. Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: Recommendations for the European setting

    AIDS, Vol. 15, Núm. 3, pp. 309-320

  4. Clinical manifestations of HIV infection in the HAART era

    AIDS Reviews, Vol. 3, Núm. 4, pp. 216-222

  5. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and quantiplex HIV-1 RNA version 3.0

    Journal of Clinical Microbiology, Vol. 39, Núm. 3, pp. 862-870

  6. Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

    AIDS, Vol. 15, Núm. 13, pp. 1701-1706

  7. Episodios oportunistas en pacientes infectados por el virus de la inmunodeficiencia humana durante los primeros 6 meses de la terapia antirretroviral de gran actividad

    Medicina Clinica, Vol. 117, Núm. 3, pp. 81-84

  8. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C

    American Journal of Gastroenterology, Vol. 96, Núm. 1, pp. 179-183

  9. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

    AIDS Research and Human Retroviruses, Vol. 17, Núm. 16, pp. 1467-1471

  10. Intensification of antiretroviral therapy

    AIDS Research and Human Retroviruses, Vol. 17, Núm. 6, pp. 499-506

  11. Management of hepatitis C in HIV-infected persons

    Antiviral Research, Vol. 52, Núm. 2, pp. 189-198

  12. Molecular evidence of homosexual transmission of HIV type 2 in Spain

    AIDS Research and Human Retroviruses, Vol. 17, Núm. 5, pp. 417-422

  13. Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays

    Journal of Medical Virology, Vol. 64, Núm. 3, pp. 217-222

  14. Naturally occurring sequence polymorphisms within HIV type 1 group O protease

    AIDS Research and Human Retroviruses, Vol. 17, Núm. 16, pp. 1555-1561

  15. Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies

    Clinical Microbiology and Infection, Vol. 7, Núm. 12, pp. 678-681

  16. Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patients

    Intervirology, Vol. 44, Núm. 6, pp. 339-343

  17. Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5

    Journal of Clinical Microbiology, Vol. 39, Núm. 5, pp. 1850-1854

  18. Primary HIV-1 drug resistance in spain before and after the introduction of protease inhibitors

    Journal of Medical Virology, Vol. 63, Núm. 2, pp. 85-87

  19. Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

    Journal of Acquired Immune Deficiency Syndromes, Vol. 26, Núm. 2, pp. 145-150

  20. Primary resistance to antiretroviral agents

    Enfermedades infecciosas y microbiología clínica, Vol. 19, Núm. Monografico, pp. 22-25